Symbiotec Pharmalab IPO | The company has proposed to mop up Rs 150 crore via issuance of fresh shares, while existing shareholders will be selling up to Rs 2,030 crore worth shares via offer-for-sale.
Rosewood, Motilal Oswal-backed Symbiotec Pharmalab files draft papers to raise Rs 2,180 crore via IPO
